(Q43877542)

27 November 2017

title

Preoperative chemotherapy for esophageal cancer with paclitaxel and carboplatin: results of a phase II trial (English)

1 reference

27 November 2017

main subject

phase II clinical trial

0 references

1 reference

1 reference

1 reference

1 reference

Keresztes RS

1

1 reference

27 November 2017

Port JL

2

1 reference

27 November 2017

Pasmantier MW

3

1 reference

27 November 2017

Korst RJ

4

1 reference

27 November 2017

Altorki NK

5

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 November 2003

1 reference

The Journal of Thoracic and Cardiovascular Surgery

27 November 2017

published in

1 reference

27 November 2017

volume

126

1 reference

27 November 2017

issue

5

1 reference

27 November 2017

page(s)

1603-1608

1 reference

Esophageal cancer: results of an American College of Surgeons Patient Care Evaluation Study.

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2900710-4

Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2900710-4

Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: a prospective randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2900710-4

Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2900710-4

Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2900710-4

Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2900710-4

A comparison of multimodal therapy and surgery for esophageal adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2900710-4

Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2900710-4

Should en bloc esophagectomy be the standard of care for esophageal carcinoma?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2900710-4

Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2900710-4

Concurrent preoperative chemotherapy and radiation therapy in localized esophageal adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2900710-4

Activity of taxol in patients with squamous cell carcinoma and adenocarcinoma of the esophagus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2900710-4

En bloc esophagectomy improves survival for stage III esophageal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2900710-4

10.1016/S0022-5223(03)00710-4

7 January 2021

Identifiers

DOI

1 reference

27 November 2017

1 reference